• 1
    Watson P,Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993; 71: 67785.
  • 2
    Aarnio M,Sankila R,Pukkala E,Salovaara R,Aaltonen LA,de la Chapelle A,Peltomäki P,Mecklin J-P,Järvinen HJ. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 21418.
  • 3
    Vasen HFA,Morreau H,Nortier JWR. Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet 2001; 68: 15334.
  • 4
    Boyd J,Rhei E,Federici MG,Borgen PI,Watson P,Franklin B,Karr B,Lynch J,Lemon SJ,Lynch HT. Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Res Treat 1999; 53: 8791.
  • 5
    Vasen HFA,Möslein G,Alonso A,Bernstein I,Bertario L,Blanco I,Burn J,Capella G,Engel C,Frayling I,Friedl W,Hes FJ, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44: 35362.
  • 6
    Kalbfleisch JD,Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980.
  • 7
    Allison P. Survival analysis using the SAS system. Cary, NC: SAS Institute, 1995.
  • 8
    Surveillance EaERSPwscgSSD. Incidence-SEER 9 Regs Public-Use, Nov 2005 Sub (1973–2003)—Linked to County Attributes—Total US, 1969–2003 Counties. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006, based on the November 2005 submission. Available from: URL: Accessed 8 March 2007.
  • 9
    Surveillance Research Program NCI. SEER*Stat software. Surveillance Research Program, National Cancer Institute 2007 (version 6.2.4.) Available from: URL: Accessed 8 March 2007.
  • 10
    Kleinbaum DG,Kupper LL,Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold Company, 1982.
  • 11
    Lindor NM,Petersen GM,Hadley DW,Kinney AY,Miesfeldt S,Lu KH,Lynch P,Burke W,Press N. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006; 296: 150717.
  • 12
    Vasen HFA,Stormorken A,Menko FH,Nagengast FM,Kleibeuker JH,Griffioen G,Taal BG,Moller P,Wijnen JT. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001; 19: 407480.
  • 13
    Ferlay J,Bray F,Pisani P,Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide IARC Cancerbase no. 5, version 2.0. Lyon: IARC Press, 2004.
  • 14
    Murphy WM. What's the trouble with cytology? J Urol 2006; 176: 23436.
  • 15
    Brown GJ,St.John DJ,Macrae FA,Aittomaki K. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance. Gynecol Oncol 2001; 80: 3469.
  • 16
    Goecke T,Schulmann K,Engel C,Holinski-Feder E,Pagenstecher C,Schackert HK,Kloor M,Kuntsmann E,Vogelsang H,Keller G,Dietmaier W,Mangold E, et al. Genotype–phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 2006; 24: 18.
  • 17
    Park YJ,Shin K-H,Park J-G. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 2000; 6: 29948.
  • 18
    ten Kate GL,Kleibeuker JH,Nagengast FM,Craanen M,Cats A,Menko FH,Vasen HFA. Is surveillance of the small bowel indicated for Lynch syndrome families? Gut 2007; 56: 1198201.
  • 19
    Park J-G,Kim D-W,Hong CW,Nam B-H,Shin Y-K,Hong S-H,Kim I-J,Lim S-B,Aronson M,Bisgaard ML,Brown GJ,Burn J, et al. Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: international society for gastrointestinal hereditary tumours collaborative study. Clin Cancer Res 2006; 12: 338993.
  • 20
    Vasen HFA,Sanders EACM,Taal BG,Nagengast FM,Griffioen G,Menko FH,Kleibeuker JH,Houwing-Duistermaat JS,Meera Khan P. The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer 1996; 65: 4225.
  • 21
    Lagerstedt Robinson K,Liu T,Vandrovcova J,Halvarsson B,Clendenning M,Frebourg T,Papadopoulos N,Kinzler KW,Vogelstein B,Peltomäki P,Kolodner RD,Nilbert M, et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007; 99: 2919.
  • 22
    Bourne TH,Campbell S,Reynolds K,Hampson J,Bhatt L,Crayford TJ,Whitehead MI,Collins WP. The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer. Gynecol Oncol 1994; 52: 37985.
  • 23
    Carayol J,Khlat M,Maccario J,Bonaiti-Pellie C. Hereditary non-polyposis colorectal cancer: current risks of colorectal cancer largely overestimated. J Med Genet 2002; 39: 3359.